Genelux (GNLX) Return on Sales (2022 - 2024)

Genelux's Return on Sales history runs 3 years deep, the most recent figure standing at 40.71% for Q4 2024.

• On a quarterly basis, Return on Sales fell 3255.0% year-over-year to 40.71% in Q4 2024; TTM through Dec 2024 was 40.71%, a 3255.0% decrease from a year earlier, with the FY2025 full-year figure at 138.78%, down 2414.0% from the prior year.
• Return on Sales declined to 40.71% in Q4 2024 per GNLX's latest filing, from 37.35% in the prior quarter.
• Across five years, Return on Sales topped out at 0.13% in Q3 2023 and bottomed at 40.71% in Q4 2024.
• The 3-year median for Return on Sales is 5.93% (2023), against an average of 13.76%.
• Across the five-year window, Return on Sales rose 12 bps in 2023 and sank 3747 bps in 2024, its largest moves.
• Year by year, Return on Sales stood at 0.0% in 2022, then slumped by 253181 bps to 8.17% in 2023, then slumped by 398 bps to 40.71% in 2024.
• Per Business Quant, the three latest GNLX Return on Sales figures stand at 40.71% (Q4 2024), 37.35% (Q3 2024), and 35.42% (Q2 2024).